CVS Health Corporation (ETR:CVS)
Market Cap | 76.58B |
Revenue (ttm) | 358.02B |
Net Income (ttm) | 4.46B |
Shares Out | n/a |
EPS (ttm) | 3.54 |
PE Ratio | 17.18 |
Forward PE | n/a |
Dividend | 2.49 (4.07%) |
Ex-Dividend Date | Jan 23, 2025 |
Volume | 3,862 |
Average Volume | 1,594 |
Open | 61.97 |
Previous Close | 62.58 |
Day's Range | 58.85 - 62.30 |
52-Week Range | 41.68 - 73.84 |
Beta | n/a |
RSI | 64.71 |
Earnings Date | Feb 12, 2025 |
About CVS Health
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPs and Medicaid health care management services. It serves employer groups, individuals, coll... [Read more]
Financial Performance
In 2024, CVS Health's revenue was $370.66 billion, an increase of 3.93% compared to the previous year's $356.62 billion. Earnings were $4.61 billion, a decrease of -44.70%.
Financial numbers in USD Financial StatementsNews

Behind the Scenes of CVS Health's Latest Options Trends
Financial giants have made a conspicuous bearish move on CVS Health. Our analysis of options history for CVS Health (NYSE: CVS) revealed 8 unusual trades. Delving into the details, we found 25% of tr...

DOJ Investigates UnitedHealth, Probe Accuses Of Inflating Medicare Diagnoses
The Justice Department has reportedly launched a civil fraud investigation into UnitedHealth Group Inc’s (NYSE: UNH) Medicare billing practices. The probe began in recent months and will examine Unit...
CVS Health Stock Gets RS Rating Upgrade
A Relative Strength Rating upgrade for CVS Health shows improving technical performance. Will it continue?

Thermo Fisher Scientific Elects New Director to Board
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced Karen S. Lynch has been elected to its board of directors, effective Feb...
CVS director picks up another 30,000 shares

My Dividend Stock Portfolio: New January Dividend Record - 100 Holdings With 14 Buys
January saw solid investment activity with $1,500 in net capital added, primarily into Business Development Companies like Owl Rock Capital, Goldman Sachs BDC, and Blackstone Secured Lending Fund. Div...

Top 2 cheap stocks to buy for 2025
The US consumer price index (CPI) was up more than expected in January, raising doubts about the Federal Reserve's ability to lower interest rates further in 2025.
CVS Health: One Good Quarter Is Not Enough; Retain Sell

High-cost sickle cell gene therapies push insurers and Medicaid programs to find new payment models
Deshawn "DJ" Chow is one of just over 100 sickle cell patients who have undergone treatment with new gene therapies. CVS Health CEO David Joyner said private insurers and employer-sponsored health pla...
CVS Health Corp Appoints Ed DeVaney as President of CVS Caremark
CVS Health Corp Appoints Ed DeVaney as President of CVS Caremark

Ed DeVaney named President of CVS Caremark
WOONSOCKET, R.I. , Feb. 17, 2025 /PRNewswire/ -- Today, CVS Health® (NYSE: CVS) named Ed DeVaney president of the company's CVS Caremark pharmacy benefit management business.

Super Micro Computer, Intel, Alibaba And CVS Are Among Top 13 Large-Cap Gainers Last Week (Feb 10-Feb 14): Are The Others In Your Portfolio?
These thirteen large-cap stocks were the best performers in the last week. Are they in your portfolio? Hims & Hers Health, Inc. (NYSE: HIMS) stock escalated 42.12% last week. The stock may have gaine...
Notable healthcare headlines for the week: J&J, CVS, Moderna, Biogen in focus

3-Stocks to love or leave: Intel, CVS Health, Boeing
Tim Seymour, Seymour Asset Management, joins' Power Lunch' to discuss his plays for three stocks.
Prem Watsa's Strategic Moves: CVS Health Corp Takes Center Stage with 7.82% Portfolio Share
Prem Watsa's Strategic Moves: CVS Health Corp Takes Center Stage with 7.82% Portfolio Share
Wolfe Research Raises CVS Health (CVS) Price Target to $80
Wolfe Research Raises CVS Health (CVS) Price Target to $80

Why CVS Stock Thrashed the Market on Thursday

CVS Health Gains Momentum After Q4 Performance, Analyst Upgrades Stock
On Wednesday, CVS Health Corp (NYSE: CVS) reported fourth-quarter sales of $97.71 billion, beating the consensus of $97.19 billion . Total revenues increased 4.2%, driven by growth in the Health Care...

CVS Health Gains Momentum After Q4 Performance, Analyst Upgrades Stock
On Wednesday, CVS Health Corp CVS reported fourth-quarter sales of $97.71 billion, beating the consensus of $97.19 billion.

CVS shares are up 45% this year here's why it may be starting to turn its business around
Some analysts are more optimistic about CVS' ability to navigate higher-than-expected medical costs in its insurance unit moving forward.
CVS wins upgrade to buy as analyst sees more upside potential than its peers
A Leerink analyst says CVS is starting to benefit from stabilization in its Aetna health-insurance and pharmacy-benefits businesses.

These Analysts Boost Their Forecasts On CVS Health Following Upbeat Earnings
CVS Health Corp (NYSE: CVS) reported upbeat earnings for its fourth quarter on Wednesday . The company posted fourth-quarter sales of $97.71 billion, beating the consensus of $97.19 billion. Adjusted...

These Analysts Boost Their Forecasts On CVS Health Following Upbeat Earnings
CVS Health Corp CVS reported upbeat earnings for its fourth quarter on Wednesday.

Here are Thursday's biggest analyst calls: Nvidia, Netflix, Coinbase, CVS, Broadcom, Dell, Robin Hood, Walmart & more
Here are the biggest calls on Wall Street on Thursday.

Reagan's Sugar Quotas, Trump's Tariffs, And The Price Of Protectionism: Here's Why Coke And Pepsi In US Have High Fructose Corn Syrup Instead Of Sugar
The reason U.S. soft drinks primarily use high fructose corn syrup instead of sugar dates back to a trade barrier imposed by former President Ronald Reagan in the 1980s. This policy echoes in today’s ...